March 2025
Published: 03 Mar 2025
Author: Precedence Research
The Children's Brain Tumor Network (CBTN) has included the Carson Leslie Foundation in its executive council to hasten research, improve treatment options, and strengthen advocacy for children with brain tumors. The Carson Leslie Foundation was founded in memory of Carson Leslie and has supported many of the projects undertaken by CBTN over the past 4 years, with the latest contribution of $100,000 going toward the CBTN medulloblastoma liquid biopsy project. CBTN Executive Director Jena Lilly expressed excitement about getting a stronger working relationship with its partners and said that cooperation among research institutions, medical practitioners, and advocacy groups is essential for advancing the treatment of pediatric brain cancer.
The Carson Leslie Foundation is aggressively supporting research for improving treatment and cures for pediatric brain tumors. Most importantly, joining the CBTN Executive Council allows the foundation to support cutting-edge research such as the medulloblastoma liquid biopsy, which may well revolutionize monitoring treatment progress. It also envisions further collaboration by working with CBTN and other partners to speed up progress across clinical focus. In addition, the foundation is actively advocating policy and awareness-raising efforts to increase awareness and policy changes benefiting children with brain tumors.
The Carroll Leslie Foundation has stepped in to financially support the liquid biopsy project from medulloblastoma - a process likely to minimize the application of invasive monitoring techniques for children with highly aggressive brain tumors مثل medulloblastoma. The project involves the identification of tumor-derived biomarkers in blood or cerebrospinal fluid to provide minimally invasive monitoring, early treatment response detection, and personalized treatment regimens. Such an approach would thus improve outcomes and reduce the giving of unnecessary sequelae in a young patient with an additional burden of surgery, radiation, and chemotherapy.
Ripley Martin, a Board Member of the Carson Leslie Foundation highlighted how necessary it was for pediatric brain tumor organizations to coordinate their activities. In her words, from the united front, they will make a difference in the lives of children across all the different diagnoses of brain tumors within the organization. Many shared voices within the field of pediatric oncology are propagating an idea based on data sharing, multi-institutional research collaboration, and advocacy to achieve the intended goal of maximized impact.
The Carson Leslie Foundation is joining forces with the Children's Brain Tumor Network to promote improvement in pediatric brain cancer research. Expand liquid biopsy research, which could include other pediatric brain tumors, and create new treatment strategies. Funding support from the foundation can accelerate the discovery of novel treatments. Annually, open-access data has been made available by CBTN to ensure that the findings benefit the entire pediatric cancer research community. This collaboration, because of the committed funding, advocacy, and innovative projects such as the medulloblastoma liquid biopsy initiative, can be expected to transform pediatric oncology and will bring new hope to children and families facing these grave diseases.
March 2025
March 2025
March 2025
March 2025